A tumor-suppressing mechanism in Drosophila involving cell competition and the Hippo pathway.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20679206.
- Also identified by DOI 10.1073/pnas.1009376107 and PMC identifier 2930466.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mutant larvae for the Drosophila gene lethal giant larva (lgl) develop neoplastic tumors in imaginal discs. However, lgl mutant clones do not form tumors when surrounded by wild-type tissue, suggesting the existence of a tumor-suppressing mechanism. We have investigated the tumorigenic potential of lgl mutant cells by generating wing compartments that are entirely mutant for lgl and also inducing clones of various genetic combinations of lgl(-) cells. We find that lgl(-) compartments can grow indefinitely but lgl(-) clones are eliminated by cell competition. lgl mutant cells may form tumors if they acquire constitutive activity of the Ras pathway (lgl(-) UAS-ras(V12)), which confers proliferation advantage through inhibition of the Hippo pathway. Yet, the majority of lgl(-) UAS-ras(V12) clones are eliminated in spite of their high proliferation rate. The formation of a tumor requires in addition the formation of a microenvironment that allows mutant cells to evade cell competition.
Medical subject headings
- Drosophila Proteins
- Drosophila melanogaster
- Intracellular Signaling Peptides and Proteins
- Protein Serine-Threonine Kinases
- Tumor Suppressor Proteins